Cerebral infarction is not able to speak, mainly should be given speech function rehabilitation training, acupuncture treatment, and drug therapy to actively control cerebral infarction. Pharmacological treatment mainly includes ultra-early patients, such as within six hours of onset, and intravenous thrombolytic therapy should be given as much as possible when thrombolysis is suitable, and alteplase and urokinase are generally applied in the clinic. If the time window for thrombolysis is exceeded and thrombolysis is not suitable, aspirin should be given as early as possible to fight platelet aggregation, and clopidogrel can be given if aspirin is not tolerated, and neuroprotection, as well as improvement of blood circulation and protection of mitochondria should be given at the same time. Drugs to improve blood circulation include suxamethonium, vincristine, and chuanxiongxizine; neuroprotective drugs include edaravone, cytarabine, cerebral protein hydrolyzate, and also olaplatasetam and piracetam. If the patient’s signs and symptoms of somatic function are severe, butylphthalide can be given at the same time to improve the signs and symptoms of neurological deficits. When the condition is stabilized, rehabilitation should be given as early as possible.